VT: Drug makers told to explain price hikes

Burlington Free Press: MONTPELIER - Vermont is poised to become the first state requiring drug companies to explain their price increases, and Bob and Deborah Messing think that’s a good idea.

The Messings live in Montpelier and are in their early 70s. She’s on Orencia, a Bristol-Myers Squibb product, for rheumatoid arthritis. He recently finished a course of Harvoni, made by Gilead Sciences Inc., to treat hepatitis C.

Read article

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending